SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Human Genome Sciences, Inc. (HGSI)
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
1127 105 0 HGSI
Emcee:  Jeffrey Ogbar Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
977ANALYSIS-Spotlight on Glaxo heart drug as others fail Thu Apr 12, 2007 8:28AM EDbob zagorin-4/13/2007
976Another SLE contender... 5:00PM Genelabs Technologies Receives Agreement From FIan@SI-4/2/2007
975xml.10kwizard.combob zagorin-3/29/2007
974annual meeting notice xml.10kwizard.combob zagorin-3/21/2007
973MedImmune and HGS now roomies Friday March 16, 9:12 am ET Human Genome Sciencesbob zagorin-3/16/2007
972xml.10kwizard.combob zagorin-3/5/2007
971<i>Am I missing something in regard to what ITT means?</i> No, yourDewDiligence_on_SI-3/1/2007
970Dew, You said <<The reason for the turnaround is the lack of dropouts in Steven Rachbach-3/1/2007
969<i>…at this point (very near the finish line), the 1200 q4w group was onlyDewDiligence_on_SI-3/1/2007
968new coverage Human Genome HGSI Stanford Research Holdbob zagorin-3/1/2007
967Dew, That part of the Q&A was quite interesting; it looks like they will geSteven Rachbach-3/1/2007
966The non-inferiority threshold in the two phase-3 Albuferon trials is 6% (12% if DewDiligence_on_SI-2/27/2007
965Glaxo and HGS's Announcement: Reading Between the Lines (seeking alpha) Frebob zagorin-2/21/2007
964Human Genome Sciences and GlaxoSmithKline Announce Initiation of Phase 3 Clinicabob zagorin-2/13/2007
963Human Genome Sciences (HGSI) (11.58 +0.04) GLAXOSMITHKLINE PLC and HUMAN GENOMEbob zagorin-2/13/2007
962HCV Report from Susquehanna: investorshub.comDewDiligence_on_SI-2/1/2007
961Coverage Initiated Company Ticker Brokerage Firm Ratings Change Price Targebob zagorin-1/31/2007
960apparently ms wasn't all that impressed because they initiated coverage withbob zagorin-1/29/2007
959Starting to look like some interesting progress is being made... Human Genome SIan@SI-1/8/2007
958Coverage Initiated Sort alphabetically | Sort by brokers Company Ticker Brokebob zagorin-1/4/2007
957>>Smallpox: run for the hills<< From an epidemiological perspectivenigel bates-12/31/2006
956<i>getting my bioterror threats mixed up.</i> Here’s how to keep thDewDiligence_on_SI-12/22/2006
955>>Happy Holidays<< You too, and all the best for the new year. Nignigel bates-12/22/2006
954Oh, right, brain failure there . . . getting my bioterror threats mixed utuck-12/22/2006
953They kind of fell off the radar since the exile to the pink sheets, though I posnigel bates-12/22/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News